Categories Earnings, Health Care

UnitedHealth Group beats Q4 earnings estimates; revenues match expectations

UnitedHealth Group (NYSE: UNH) reported better-than-expected earnings for the fourth quarter of 2019 while revenues matched estimates. Shares were down 0.40% in premarket hours on Wednesday.

Total revenues of $61 billion was up 5% from the same period last year and in line with forecasts.  

UnitedHealth Group reports Q4 2019 earnings results

Net earnings attributable to UnitedHealth Group common shareholders was $3.5 billion, or $3.58 per share, compared to $3 billion, or $3.10 per share, last year. Adjusted EPS grew 19% to $3.90, beating estimates of $3.28.  

Favorable medical reserve development was $270 million in the quarter, with $150 million related to 2019 and $120 million related to previous years. Year-end days claims payable were 50.8 days compared to 49.5 in the fourth quarter of 2018. Medical costs increased 8% in the period.

Also read: BlackRock Q4 2019 Earnings Snapshot

During the quarter, revenues in the UnitedHealthcare segment increased 4% to $48.2 billion versus the prior-year period. Revenues in the Optum segment increased 7% year-over-year to $29.8 billion.

Revenues from premiums increased 6%. Revenues from products decreased slightly during the quarter while services revenues increased. Revenues from investment and other income rose 26%.

For the full year of 2020, GAAP EPS is expected to be $15.45 to $15.75 and adjusted EPS is expected to be $16.25 to $16.55.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top